 | • レポートコード：D0804-09791 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペプチド治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペプチド治療の種類別市場規模（注射、経口、その他）、用途別市場規模（がん、代謝障害、中枢神経系、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Ipsen、Takeda、Eli Lilly、AstraZeneca、Novo Nordisk、Allergan、Novartis、Teva、AbbVie、Ferring、The Medicines、Merck、J & J ・地域別グローバル市場分析 2015年-2020年 ・ペプチド治療の北米市場（アメリカ、カナダ、メキシコ） ・ペプチド治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペプチド治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペプチド治療の南米市場（ブラジル、アルゼンチン） ・ペプチド治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、経口、その他 ・用途別分析：がん、代謝障害、中枢神経系、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Peptide Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Peptide Therapeutics sales will be xx in 2020 from Peptide Therapeutics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Peptide Therapeutics market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Peptide Therapeutics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Peptide Therapeutics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Peptide Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peptide Therapeutics market has been segmented into
Injection
Oral
Other
By Application, Peptide Therapeutics has been segmented into:
Cancer
Metabolic Disorders
Central Nervous System
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peptide Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Peptide Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peptide Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Peptide Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Peptide Therapeutics Market Share Analysis
Peptide Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peptide Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peptide Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Peptide Therapeutics are:
Sanofi
Ipsen
Takeda
Eli Lilly
AstraZeneca
Novo Nordisk
Allergan
Novartis
Teva
AbbVie
Ferring
The Medicines
Merck
J & J
Among other players domestic and global, Peptide Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptide Therapeutics, with price, sales, revenue and global market share of Peptide Therapeutics in 2018 and 2019.
Chapter 3, the Peptide Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Peptide Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Peptide Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Peptide Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptide Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptide Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Overview of Global Peptide Therapeutics Market
1.4.1 Global Peptide Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Peptide Therapeutics Industry Impact
1.6.1 COVID-19 Potential Implications for the Peptide Therapeutics
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Peptide Therapeutics
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ipsen SWOT Analysis
2.2.4 Ipsen Product and Services
2.2.5 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novo Nordisk SWOT Analysis
2.6.4 Novo Nordisk Product and Services
2.6.5 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Allergan SWOT Analysis
2.7.4 Allergan Product and Services
2.7.5 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva SWOT Analysis
2.9.4 Teva Product and Services
2.9.5 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AbbVie SWOT Analysis
2.10.4 AbbVie Product and Services
2.10.5 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ferring
2.11.1 Ferring Details
2.11.2 Ferring Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ferring SWOT Analysis
2.11.4 Ferring Product and Services
2.11.5 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 The Medicines
2.12.1 The Medicines Details
2.12.2 The Medicines Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 The Medicines SWOT Analysis
2.12.4 The Medicines Product and Services
2.12.5 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Merck
2.13.1 Merck Details
2.13.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Merck SWOT Analysis
2.13.4 Merck Product and Services
2.13.5 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 J & J
2.14.1 J & J Details
2.14.2 J & J Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 J & J SWOT Analysis
2.14.4 J & J Product and Services
2.14.5 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Peptide Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Peptide Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Peptide Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Peptide Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Peptide Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Peptide Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Peptide Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Peptide Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Peptide Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Peptide Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Peptide Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Peptide Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Peptide Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Peptide Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Peptide Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Peptide Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Peptide Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Peptide Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Peptide Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Peptide Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Peptide Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Peptide Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Peptide Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Peptide Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Peptide Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Peptide Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Peptide Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Peptide Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Peptide Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Peptide Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Peptide Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Peptide Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Peptide Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Peptide Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Peptide Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Peptide Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Peptide Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Peptide Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Peptide Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Peptide Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Peptide Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Peptide Therapeutics Price by Type (2015-2020)
11 Global Peptide Therapeutics Market Segment by Application
11.1 Global Peptide Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Peptide Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Peptide Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Peptide Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Peptide Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Peptide Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Peptide Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Peptide Therapeutics Market Forecast (2021-2025)
12.2.4 South America Peptide Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Peptide Therapeutics Market Forecast (2021-2025)
12.3 Peptide Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Peptide Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Peptide Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Peptide Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Peptide Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Peptide Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Peptide Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peptide Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peptide Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Peptide Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Peptide Therapeutics Major Business
Table 10. Sanofi Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi SWOT Analysis
Table 12. Sanofi Peptide Therapeutics Product and Services
Table 13. Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Ipsen Basic Information, Manufacturing Base and Competitors
Table 15. Ipsen Peptide Therapeutics Major Business
Table 16. Ipsen Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 17. Ipsen SWOT Analysis
Table 18. Ipsen Peptide Therapeutics Product and Services
Table 19. Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Takeda Basic Information, Manufacturing Base and Competitors
Table 21. Takeda Peptide Therapeutics Major Business
Table 22. Takeda Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 23. Takeda SWOT Analysis
Table 24. Takeda Peptide Therapeutics Product and Services
Table 25. Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 27. Eli Lilly Peptide Therapeutics Major Business
Table 28. Eli Lilly Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 29. Eli Lilly SWOT Analysis
Table 30. Eli Lilly Peptide Therapeutics Product and Services
Table 31. Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 33. AstraZeneca Peptide Therapeutics Major Business
Table 34. AstraZeneca Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 35. AstraZeneca SWOT Analysis
Table 36. AstraZeneca Peptide Therapeutics Product and Services
Table 37. AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 39. Novo Nordisk Peptide Therapeutics Major Business
Table 40. Novo Nordisk Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 41. Novo Nordisk SWOT Analysis
Table 42. Novo Nordisk Peptide Therapeutics Product and Services
Table 43. Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Allergan Basic Information, Manufacturing Base and Competitors
Table 45. Allergan Peptide Therapeutics Major Business
Table 46. Allergan Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 47. Allergan SWOT Analysis
Table 48. Allergan Peptide Therapeutics Product and Services
Table 49. Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Novartis Basic Information, Manufacturing Base and Competitors
Table 51. Novartis Peptide Therapeutics Major Business
Table 52. Novartis Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 53. Novartis SWOT Analysis
Table 54. Novartis Peptide Therapeutics Product and Services
Table 55. Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Teva Basic Information, Manufacturing Base and Competitors
Table 57. Teva Peptide Therapeutics Major Business
Table 58. Teva Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 59. Teva SWOT Analysis
Table 60. Teva Peptide Therapeutics Product and Services
Table 61. Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. AbbVie Basic Information, Manufacturing Base and Competitors
Table 63. AbbVie Peptide Therapeutics Major Business
Table 64. AbbVie Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 65. AbbVie SWOT Analysis
Table 66. AbbVie Peptide Therapeutics Product and Services
Table 67. AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Ferring Basic Information, Manufacturing Base and Competitors
Table 69. Ferring Peptide Therapeutics Major Business
Table 70. Ferring Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 71. Ferring SWOT Analysis
Table 72. Ferring Peptide Therapeutics Product and Services
Table 73. Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. The Medicines Basic Information, Manufacturing Base and Competitors
Table 75. The Medicines Peptide Therapeutics Major Business
Table 76. The Medicines Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 77. The Medicines SWOT Analysis
Table 78. The Medicines Peptide Therapeutics Product and Services
Table 79. The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Merck Basic Information, Manufacturing Base and Competitors
Table 81. Merck Peptide Therapeutics Major Business
Table 82. Merck Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 83. Merck SWOT Analysis
Table 84. Merck Peptide Therapeutics Product and Services
Table 85. Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. J & J Basic Information, Manufacturing Base and Competitors
Table 87. J & J Peptide Therapeutics Major Business
Table 88. J & J Peptide Therapeutics Total Revenue (USD Million) (2018-2019)
Table 89. J & J SWOT Analysis
Table 90. J & J Peptide Therapeutics Product and Services
Table 91. J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Global Peptide Therapeutics Sales by Manufacturer (2018-2019) (K Units)
Table 93. Global Peptide Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 94. Global Peptide Therapeutics Sales by Regions (2015-2020) (K Units)
Table 95. Global Peptide Therapeutics Sales Market Share by Regions (2015-2020)
Table 96. Global Peptide Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 97. North America Peptide Therapeutics Sales by Countries (2015-2020) (K Units)
Table 98. North America Peptide Therapeutics Sales Market Share by Countries (2015-2020)
Table 99. North America Peptide Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 100. North America Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Table 101. Europe Peptide Therapeutics Sales by Countries (2015-2020) (K Units)
Table 102. Europe Peptide Therapeutics Sales Market Share by Countries (2015-2020)
Table 103. Europe Peptide Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 104. Asia-Pacific Peptide Therapeutics Sales by Regions (2015-2020) (K Units)
Table 105. Asia-Pacific Peptide Therapeutics Sales Market Share by Regions (2015-2020)
Table 106. Asia-Pacific Peptide Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 107. South America Peptide Therapeutics Sales by Countries (2015-2020) (K Units)
Table 108. South America Peptide Therapeutics Sales Market Share by Countries (2015-2020)
Table 109. South America Peptide Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 110. South America Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Table 111. Middle East & Africa Peptide Therapeutics Sales by Countries (2015-2020) (K Units)
Table 112. Middle East & Africa Peptide Therapeutics Sales Market Share by Countries (2015-2020)
Table 113. Middle East & Africa Peptide Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 114. Middle East & Africa Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Table 115. Global Peptide Therapeutics Sales by Type (2015-2020) (K Units)
Table 116. Global Peptide Therapeutics Sales Share by Type (2015-2020)
Table 117. Global Peptide Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 118. Global Peptide Therapeutics Revenue Share by Type (2015-2020)
Table 119. Global Peptide Therapeutics Sales by Application (2015-2020) (K Units)
Table 120. Global Peptide Therapeutics Sales Share by Application (2015-2020)
Table 121. Global Peptide Therapeutics Sales Forecast by Regions (2021-2025) (K Units)
Table 122. Global Peptide Therapeutics Market Share Forecast by Regions (2021-2025)
Table 123. Global Peptide Therapeutics Sales Forecast by Type (2021-2025) (K Units)
Table 124. Global Peptide Therapeutics Market Share Forecast by Type (2021-2025)
Table 125. Global Peptide Therapeutics Sales Forecast by Application (2021-2025)
Table 126. Global Peptide Therapeutics Market Share Forecast by Application (2021-2025)
Table 127. Direct Channel Pros & Cons
Table 128. Indirect Channel Pros & Cons
Table 129. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Peptide Therapeutics Picture
Figure 2. Global Sales Market Share of Peptide Therapeutics by Type in 2019
Figure 3. Injection Picture
Figure 4. Oral Picture
Figure 5. Other Picture
Figure 6. Peptide Therapeutics Sales Market Share by Application in 2018
Figure 7. Cancer Picture
Figure 8. Metabolic Disorders Picture
Figure 9. Central Nervous System Picture
Figure 10. Other Picture
Figure 11. Global Peptide Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Peptide Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Peptide Therapeutics Sales Market Share by Manufacturer in 2019
Figure 32. Global Peptide Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Peptide Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Peptide Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Peptide Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Peptide Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 39. Global Peptide Therapeutics Revenue Market Share by Regions in 2018
Figure 40. North America Peptide Therapeutics Sales and Growth Rate (2015-2020)
Figure 41. Europe Peptide Therapeutics Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2015-2020)
Figure 43. South America Peptide Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Peptide Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. North America Peptide Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Peptide Therapeutics Sales Market Share by Countries (2015-2020)
Figure 47. North America Peptide Therapeutics Sales Market Share by Countries in 2018
Figure 48. North America Peptide Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Peptide Therapeutics Revenue Market Share by Countries in 2018
Figure 50. United States Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Peptide Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Germany Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Peptide Therapeutics Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Peptide Therapeutics Revenue Market Share by Regions 2019
Figure 64. China Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Peptide Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Peptide Therapeutics Sales Market Share by Countries in 2019
Figure 71. South America Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure 72. Brazil Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Peptide Therapeutics Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Peptide Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Peptide Therapeutics Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Peptide Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Peptide Therapeutics Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Peptide Therapeutics Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Peptide Therapeutics Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Peptide Therapeutics Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Peptide Therapeutics Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
中枢神経系障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Central Nervous System Disorders Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…- ペプチドマイクロアレイの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Peptide Microarray market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptide Microarray market …
- B型ナトリウム利尿ペプチド試験の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global B-type Natriuretic Peptide Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The B-type Natriu…
- NターミナルプロB型ナトリウム利尿ペプチドの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global N-terminal Pro B-type Natriuretic Peptide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The N-t…
- 脳性ナトリウム利尿ペプチド（BNP）テストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Brain Natriuretic Peptide (BNP) Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Brain Na…